~ Product Pipeline

Acretia is a drug development and investment group with a commercial focus on patients suffering diseases with high unmet needs. We seek to develop our products in collaborations with our pharmaceutical partners. We are currently advancing the development of a product for hyper-proliferative inflammatory diseases of the skin and two products targeting unmet needs in relieving pain.

Our objectives are to acquire and partner one additional product in 2009.